LncRNA GMDS‐AS1 inhibits lung adenocarcinoma development by regulating miR‐96‐5p/CYLD signaling

por Zhao, Ming, Xin, Xiao‐Feng, Zhang, Jian‐Ya, Dai, Wei, Lv, Tang‐Feng, Song, Yong
Publicado 2019

Erlotinib-based doublet targeted therapy versus erlotinib alone in previously treated advanced non-small-cell lung cancer: a meta-analysis from 24 randomized controlled trials

por Gao, Jian-Wei, Zhan, Ping, Qiu, Xiang-Yu, Jin, Jia-Jia, Lv, Tang-Feng, Song, Yong
Publicado 2017

Skin Rash could Predict the Response to EGFR Tyrosine Kinase Inhibitor and the Prognosis for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

por Liu, Hong-bing, Wu, Ying, Lv, Tang-feng, Yao, Yan-wen, Xiao, Yong-ying, Yuan, Dong-mei, Song, Yong
Publicado 2013

Zebrafish Xenograft Model of Human Lung Cancer for Evaluating Osimertinib Resistance

por Li, Xin-ying, Huang, Li-tang, Wu, Jia-qi, He, Ming-fang, Zhu, Su-hua, Zhan, Ping, Lv, Tang-feng, Song, Yong
Publicado 2019

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib

por Zhu, You-cai, Wang, Wen-xian, Xu, Chun-wei, Zhuang, Wu, Song, Zheng-bo, Du, Kai-qi, Chen, Gang, Lv, Tang-feng, Song, Yong
Publicado 2018

Diagnostic and therapeutic value of progastrin‐releasing peptide on small‐cell lung cancer: A Single‐Center Experience in China

por Wu, Xiao‐Yuan, Hu, Yang‐Bo, Li, Hui‐Juan, Wan, Bing, Zhang, Chen‐Xi, Zhang, Bin, Hu, Huan, Zhang, Qun, Lv, Tang‐Feng, Zhan, Ping, Song, Yong
Publicado 2018

Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs

por Xu, Chun-wei, Lei, Lei, Wang, Wen-xian, Lin, Li, Zhu, You-cai, Wang, Hong, Miao, Li-yun, Wang, Li-ping, Zhuang, Wu, Fang, Mei-yu, Lv, Tang-feng, Song, Yong
Publicado 2020

Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study

por Lei, Lei, Wang, Wen‐xian, Zhu, You‐cai, Li, Jin‐luan, Fang, Yong, Wang, Hong, Zhuang, Wu, Zhang, Yin‐bin, Wang, Li‐ping, Fang, Mei‐yu, Xu, Chun‐wei, Wang, Xiao‐jia, Lv, Tang‐feng, Song, Yong
Publicado 2019

Potential mechanism of primary resistance to icotinib in patients with advanced non–small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi‐cente...

por Lei, Lei, Wang, Wen‐xian, Zhu, You‐cai, Li, Jin‐luan, Fang, Yong, Wang, Hong, Zhuang, Wu, Zhang, Yin‐bin, Wang, Li‐ping, Fang, Mei‐yu, Xu, Chun‐wei, Wang, Xiao‐jia, Lv, Tang‐feng, Song, Yong
Publicado 2020

NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma

por Zhan, Ping, Xi, Guang‐min, Zhang, Bin, Wu, Ying, Liu, Hong‐bing, Liu, Ya‐fang, Xu, Wu‐jian, Zhu, Qingqing, Cai, Feng, Zhou, Ze‐jun, Miu, Ying‐ying, Wang, Xiao‐xia, Jin, Jia‐jia, Li, Qian, Lv, Tang‐feng, Song, Yong
Publicado 2016

PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway

por Zhan, Ping, Zhang, Bin, Xi, Guang-min, Wu, Ying, Liu, Hong-bing, Liu, Ya-fang, Xu, Wu-jian, Zhu, Qing-qing, Cai, Feng, Zhou, Ze-jun, Miu, Ying-ying, Wang, Xiao-xia, Jin, Jia-jia, Li, Qian, Qian, Li-ping, Lv, Tang-feng, Song, Yong
Publicado 2017

Simultaneous VENTANA IHC and RT-PCR testing of ALK status in Chinese non-small cell lung cancer patients and response to crizotinib

por Xu, Chun-wei, Wang, Wen-xian, Chen, Yan-ping, Chen, Yu, Liu, Wei, Zhong, Li-hua, Chen, Fang-fang, Zhuang, Wu, Song, Zheng-bo, Chen, Xiao-hui, Huang, Yun-jian, Guan, Yan-fang, Yi, Xin, Lv, Tang-feng, Zhu, Wei-feng, Lu, Jian-ping, Wang, Xiao-jiang, Shi, Yi, Lin, Xian-dong, Chen, Gang, Song, Yong
Publicado 2018

Multicenter study of diagnostic procedures, genetic aberration analysis, and first‐line treatment of lung cancer in Jiangsu Province, China

por Hu, YangBo, Hu, Huan, Miao, LiYun, Zhao, Xin, Gu, Wei, Heng, Wei, Meng, ZiLi, Feng, Jian, You, Yi, Xu, XingXiang, Hu, Rong, Li, HaiQuan, Zhao, Jie, Zhu, XiaoLi, Shi, MeiQi, Shen, Li, Zhang, XiuWei, Yin, XiaoWei, Ma, Hang, Shi, MinHua, Yu, Yong, Lv, Hong, Cai, LiMing, Feng, GaoHua, Zhang, YeQing, Wu, Feng, Lv, TangFeng, Song, Yong
Publicado 2018

Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study

por Xu, Chun-Wei, Wang, Wen-Xian, Wang, Dong, Wang, Qi-Ming, Pu, Xing-Xiang, Zhu, You-Cai, Huang, Jian-Hui, Yu, Zong-Yang, Cui, Zhao-Lei, Chen, Xiao-Hui, Li, Jin-Luan, Fang, Yong, Wang, Hong, Zhuang, Wu, Lan, Shi-Jie, Cai, Xin, Zhang, Yin-Bin, Gao, Wen-Bin, Wang, Li-Ping, She, Ke-Lin, Rao, Chuang-Zhou, Zhou, Yue-Fen, Fang, Mei-Yu, Miao, Li-Yun, Lei, Lei, Lv, Tang-Feng, Song, Yong
Publicado 2020